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RESUmO
Este estudo teve por objetivo caracterizar a 
qualidade do sono de pessoas com o vírus 
da imunodeficiência humana (HIV) – AIDS 
–, com ou sem manifestações clínicas e 
sob tratamento ambulatorial. Para tal, foi 
realizada pesquisa descritiva e transversal. 
Os instrumentos utilizados foram: Questio-
nário de Caracterização Sociodemográfica 
e Clínica; Índice de Qualidade de Sono de 
Pittsburgh (PSQI-BR). Participaram da pes-
quisa 122 pacientes (55,7% de homens e 
44,3% de mulheres, com idade média de 
42,3 (± 8,9 anos), dos quais 53,3% referi-
ram apresentar sono de boa qualidade e 
46,7%, sono de má qualidade. Dormiam, 
em média, 7,3 (± 1,8) horas, com latên-
cia de 23,2 (± 26,2) minutos e eficiência 
do sono de 87,8% (± 14,4). Observou-se 
associação significativa entre o sono de 
boa qualidade e os seguintes fatores: ter 
companheiro(a); apresentar carga viral 
indetectável; manter comportamento de 
risco. Recomenda-se que os profissionais 
de enfermagem incluam sistematicamen-
te questões sobre o sono ao avaliarem o 
paciente com HIV/AIDS, detectando alte-
rações precocemente e reunindo subsídios 



















The objective of this study was to charac-
terize the sleep quality of Human Immuno-
Deficiency Virus (HIV) seropositive outpa-
tients with or without AIDS symptoms. This 
is a descriptive and cross-sectional study. 
Sociodemographic and clinical data were 
collected by means of a questionnaire, and 
sleep quality by means of the Pittsburgh 
Sleep Quality Index, Brazilian version. Par-
ticipants were 122 subjects (55.7% male, 
44.3% female; mean age 42.3 ± 8.9 years); 
53.3% reported good sleep quality and 
46.7% reported poor sleep quality. Sub-
jects reported sleeping a mean of 7.3 (± 
1.8) hours; sleep latency was 23.2 (± 26.2) 
minutes, and sleep efficiency, 87.8% (± 
14.4). A significant association was found 
between good sleep quality and: having 
a partner; undetectable viral load; and 
maintenance of risk behavior. It is recom-
mended that nursing professionals system-
atically include questions regarding sleep 
when evaluating  patients with HIV/AIDS, 
so that changes are  detected early and rel-
evant background information is obtained 






Se objetivó caracterizar la calidad del sue-
ño de portadores del virus de inmunodefi-
ciencia humana (VIH), con o sin manifesta-
ciones clínicas de SIDA y bajo tratamiento 
ambulatorio. Investigación descriptiva y 
transversal. Los instrumentos utilizados 
fueron: Cuestionario de Caracterización 
Sociodemográfica y Clínica; Índice de Ca-
lidad del Sueño de Pittsburgh (PSQI-BR). 
Participaron 122 pacientes (55,7% hom-
bres, 44,3% mujeres, edad promedio 
42,3±8,9 años), de los cuales 53,3% refirie-
ron buena calidad de sueño y 46,7% mala 
calidad. Dormían en promedio 7,3 (±1,8) 
horas, con latencia de 23,2 (±26,2) minutos 
y eficiencia del sueño de 87,8% (±14,4). Se 
observó asociación significativa entre bue-
na calidad de sueño y: tener compañero; 
carga viral indetectable; observar compor-
tamientos de riesgo. Se recomienda que 
los profesionales de enfermería incluyan 
sistemáticamente preguntas sobre el sue-
ño al evaluar al paciente con VIH/SIDA, de-
tectando alteraciones precozmente y reu-
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IntROdUctIOn
In 2009, according to the Ministry of Health, there 
were 38,538 new cases of AIDS (Acquired Immune Defi-
ciency Syndrome) in Brazil. This disease affects millions 
of people globally, although the figures have been falling 
across all countries, including Brazil(1).
AIDS can appear after the human organism has been in-
fected with the human immunodeficiency virus, referred to 
as HIV. The disease is highly progressive, with continuous vi-
ral replication in several cellular and anatomical structures, 
with results mainly related to the destruction and dysfunc-
tion of T lymphocytes, which express the antigen of the CD4 
membrane (T-CD4+ lymphocytes), as well as of other im-
mune system cells. Immunodeficiency results from the pro-
gressive depletion of T-CD4+ lymphocytes, and, in its most 
severe form, it is manifested by the emergence of opportun-
ist infections and neoplasms, which characterize AIDS(2). 
The first signs and symptoms of HIV infec-
tion are similar to those of other infectious 
diseases, such as mononucleosis (persistent 
fever, headaches, sore throat, muscular pain, 
skin rashes, palpable ganglia of the arms, neck, 
groin that persist for some time), and may range 
from one person to the other(1). The appear-
ance of opportunist infections and neoplasms 
are what define AIDS. In these situations, the 
T-CD4+ lymphocyte count is usually below 200 
cells/mm³(2).
In addition to the physiological and clini-
cal alterations, individuals with AIDS can 
suffer with altered psychological factors 
and with discrimination from society and 
also from other individuals with HIV/AIDS. 
Some years ago, discovering this diagnosis 
was the same as receiving a death sentence. 
Currently, the technological advancements, 
particularly antiretroviral therapy, have 
helped extend the lives of these individuals. However, the 
stigma involving people with HIV/AIDS persists(1,3).
AIDS is currently considered a chronic disease. Al-
though this fact minimizes its life-threatening aspect, 
the several organic, physiological, and psychological as-
pects inherent to the syndrome may increase its nega-
tive impact on quality of life. It is known that quality of 
life is closely related to several factors, including quality of 
sleep. A disturbed quality of sleep is a common aspect of 
chronic diseases, because sleep is directly affected by psy-
chophysiological disturbances, causing insomnia, daytime 
sleepiness, and a diminished capacity to perform activities 
of daily living(4). Hence, patients who become anxious be-
cause of the disease have a compromised quality of sleep, 
and may, therefore, show signs of depression(5).
Several authors point out that there are uncountable 
factors that can have a negative effect on the quality of 
sleep of individuals with HIV/AIDS. Quality of sleep and daily 
sleep are related to fatigue, anxiety, and depression, because 
fatigue is caused by multiple factors, which are interrelated(6). 
Another study reports that HIV-positive people have sleep 
quality disturbances because of the antiretroviral medication 
they take, and therefore they face a higher chance to suffer 
from these disorders. Hence, compared to patients without 
the disease, it is observed that they have twice as many sleep 
alterations (7). It is observed that the quality of sleep in pa-
tients in an advanced stage of the disease may be related to 
the number of CD4 + cells, because, the smaller the number 
of these cells, the greater the sleep-related problems, as the 
advanced disease causes symptoms such as pain, diarrhea, 
incontinence, fever, coughing, and dyspnea(8).
It is known that sleep disturbances may be an expres-
sive impact factor on people’s lives. They may relate to 
insomnia, respiratory disorders, depression, and noctur-
nal movement disorders. One bad night’s sleep can cause 
harms in the short, mid or long terms, be-
cause it affects one’s daily activities and pro-
fessional performance, in addition to caus-
ing mood and physiological alterations(9).
 Therefore, literature has given more and 
more evidence regarding the relevance of as-
sessing quality sleep as part of the clinical as-
sessment of patients which chronic diseases, 
and it should be recognized and promptly 
implemented by healthcare professionals. 
Regarding patients with HIV/AIDS, a popula-
tion which is expected to present a consider-
able prevalence of sleep-related complaints, 
it is essential to identify those complaints in 
order to estimate their effects on quality of 
life and, above all, seek the knowledge to 
support any necessary interventions. 
Based on the information about the qual-
ity of sleep of HIV/AIDS patients, it is possible 
to provide nurses with the necessary informa-
tion to permit them to plan interventions aiming to improve 
care, covering this aspect that is often disregarded, and, thus, 
promote a better quality of life to these individuals.
ObJEctIVE
To characterize the quality of sleep of individuals with 
HIV/AIDS, with or without clinical AIDS symptoms.
mEtHOd
This exploratory, descriptive study was performed 
using a quantitative approach. The study locations were 
three clinics of a university hospital in Southeast Brazil: 
Day Hospital for AIDS patients (DH-Aids); outpatient clinic 
of communicable diseases; Center for Clinical Research on 
HIV/AIDS (CCR).
Based on the 
information about the 
quality of sleep of HIV/
AIDS patients, it is 
possible to provide 
nurses with the 
necessary information 
to permit them to plan 
interventions aiming to 
improve care, covering 
this aspect that is often 
disregarded, and, 
thus, promote a better 
quality of life to these 
individuals.
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The subjects were 122 patients, of both genders, who 
met the following inclusion criteria: age equal to or above 
18 years; having the clinical and cognitive conditions re-
quired to answer the proposed instruments; voluntary 
participation in the study, sign the Free and Informed Con-
sent Form.
After receiving authorization from the referred ser-
vices, the patients were approached at the location of 
their appointments, when a presentation of the study was 
made and they were invited to participate. Patients who 
agreed signed the Free and Informed Consent Form, and 
the researcher applied the instruments in the form of an 
interview, reading them out for each patient and record-
ing their answers. 
The interviews were conducted using semi-structured 
forms, which included questions regarding the patients’ 
identification, socioeconomic profile, as well as their 
health and treatment history. The Pittsburgh Sleep Qual-
ity Index (PSQI-BR) was used to assess quality of sleep 
and sleep disturbances. The PSQI-BR has been validated 
for the Portuguese language and assesses the quality of 
sleep for the last month preceding the interview. It has 19 
questions that comprise seven assessment components: 
quality of sleep, latency, duration, efficiency, nocturnal 
sleep disturbances, use of sleep medication, and daytime 
sleepiness. Each component receives a score from zero 
to three, in a way that the final score on the instrument 
can range between zero and 21. The higher the score, the 
worse the quality of sleep, and scores higher than five in-
dicate poor sleep quality(4,10).
Data analysis was performed using descriptive statistics 
(central tendency and dispersion; absolute numbers and 
percentiles); Chi-Square or Fisher’s Exact tests were used 
to assess the association between quality of sleep (good 
or bad) and the categorical variables; Mann-Whitney test 
to compare the patients with good or poor quality of sleep 
considering the numerical variables; Cronbach alpha coef-
ficient to measure the internal consistency of the PSQI-BR.
The study was approved by the Research Ethics Com-
mittee of the Institution on April 8, 2009 (protocol CEP 
256/2009), in compliance with Resolution 196/96 of the 
National Health Council, which regulates human research in 
Brazil.
RESULtS
Interviews were performed with 122 patients; 68 men 
(55.7%) and 54 women (44.3%). The patients’ mean age 
was 42.2 (± 9.0) years, with a median of 41.9 years. It 
should be noted that 86 patients (70.5%) were between 
31 and 50 years of age, and only three (2.5%) were older 
than 60 years. Most patients (64 or 52.4%) reported hav-
ing a partner. The mean years of formal education was 8.1 
(± 3.8), with a median of 8.0. The reported mean family 
income was 3.7 minimum salaries (± 4.3) and a median 
of 2.5. Regarding occupation, 63 (51.6%) patients referred 
being employed, 34 (27.9%) retired or unemployed, 24 
(19.7%) inactive, and one (0.8%) did not reply. 
The patients’ mean time since the HIV diagnosis was 
9.9 years (± 5.8) with a median of 10 years, and the mean 
time of treatment was 8.1 years (±5.2), with a median of 
8.5 years. Regarding the means of HIV infection, it was 
observed for 81 patients (66.4%) the means of infection 
was sexual, through their partner, former partner, or a 
casual sexual relationship, and 30 patients (24.5%) were 
unable to refer how they became infected or provided du-
bious information. Only 10 (8.2%) patients were infected 
through blood contact (drug use or transfusion). Nineteen 
patients (15.6%) reported maintaining the risk behavior. 
Regarding the stage of the disease, 31 patients (25.4%) 
were in stage A (comprising subtypes A1, A2 and A3); 13 
patients (10.6%) in stage B (including subtypes B1, B2 and 
B3); and 76 patients (62.3%), in stage C (subtypes C1, C2 
and C3). Regarding treatment, 112 patients (91.8%) used 
retroviral drugs, and 50 (41%) used the non-nucleoside re-
verse transcriptase inhibitor efavirenz. The viral load was 
undetectable in 72 patients (59%). The medical records of 
two (1.7%) patients did not provide the necessary data. 
It was found that 65 patients (53.3%) reported having 
good sleep quality, whereas 57 (46.7%) reported poor sleep 
quality, according to the score obtained on the PSQI-BR. 
The mean score was 6.1 (± 4.1), with a median of 5.0. The 
internal consistency of the instrument, for this specific pop-
ulation, was satisfactory and with a Cronbach alpha = 0.74.
Table 1 lists the sociodemographic and clinical char-
acteristics that showed a significant association with the 
participants’ quality of sleep.
According to the data on Table 1, a significant asso-
ciation was observed between the quality of sleep and 
the following variables: marital status, with a higher per-
centage of good quality sleep among patients living with 
a partner; maintaining the risk behavior, with a smaller 
percentage of patients with poor quality of sleep among 
those who reported maintaining the risk behavior; taking 
efavirenz, with a higher percentage of patients with poor 
quality of sleep among those who did not take efavirenz; 
viral load, with a greater percentage of patients with good 
quality of sleep among those with an undetectable viral 
load.
No significant association was observed between qual-
ity of sleep and the following variables: gender, occupa-
tion, means of infection with HIV, stage of the disease, 
and number of antiretroviral drugs in use.
Furthermore, the Mann-Whitney test did not show 
any significant difference between patients with good and 
poor quality sleep regarding the following variables: age, 
education, family income, number of individuals in the 
household, time since diagnosis, time of treatment, CD4-
cell count, number of antiretroviral drugs in use, and the 
number of other drugs in use.
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Table 2 illustrates the results referring to the habitual 
sleep characteristics of patients divided into groups ac-
cording to the quality of sleep. 
A significant difference was observed among pa-
tients with good and poor quality sleep, according 
to the PSQI-BR, in terms of the following habitual 
sleep characteristics: latency; sleep duration and 
sleep efficiency. No significant difference was ob-
served regarding the bedtimes and wakeup times 
(Table 2).
Table 1 – Sociodemographic and clinical characteristics with a significant association with the quality of sleep of patients with HIV/
AIDS treated at a university hospital - Campinas, 2009
Variables
Sleep quality
p*Good (n = 65) Poor (n = 57)
n (%) n (%)
Marital status Living with a partner 42 (34.4) 22 (18.0)
0.004*
Living without a partner 23 (18.8) 35 (28.7)
Risk behavior Maintains 15 (12.3) 4 (3.3)
0.04†Does not maintain 48 (39.3) 52 (42.6)
No information 2 (1.6) 1 (0.8)
Takes efavirenz Yes 32 (26.2) 18 (14.8)
0.00 †No 25 (20.5) 37 (30.3)
No antiretroviral drug un use 8 (6.6) 2 (1.6)
Viral load Detectable 23 (18.9) 22 (18.0)
0.04†Undetectable 42 (34.4) 30 (24.6)
 No information - 5 (0.41)
Table 2 – Comparison of habitual sleep characteristics between patients with good and poor quality sleep - Campinas, 2009
Habitual sleep characteristics
Good quality sleep (n = 65) Poor quality sleep (n = 57)
Mean SD† Median Mean SD† Median
Bedtime 22h35 75 22h30 22h46 109 22h30
Latency (min.)* 15 14 10 32 33 20
Wakeup time 6h53 95 6h45 6h50 94 6h45
Duration of sleep* (hours) 8.1 1.3 8.0 6.4 1.8 6.0
Efficiency (%)* 95 8 97 80 16 82
* variables in which p < 0.05 in the Mann-Whitney test   † SD = standard deviation
Table 3 lists the score on each component of the PSQI-
BR, as well as the overall score on the instrument, of pa-
tients with good and poor quality sleep.
According to the data on Table 3, a significant difference 
was observed between patients with good and poor quality 
of sleep, for all components of the PSQI-BR (p < 0.05).
Table 3 – Comparison of the overall and individual component score of the PSQI-BR among patients with good and poor quality sleep 
- Campinas, 2009
PSQI- BR components
Good quality sleep (n = 65) Poor quality sleep (n = 57)
Mean SD† Median Mean SD† Median
C1 – Quality of sleep* 0.8 0.5 1.0 1.7 0.8 2.0
C2 – Sleep latency* 0.7 0.8 1.0 2.0 0.9 2.0
C3 – Duration of sleep* 0.2 0.4 0.0 1.2 1.2 1.0
C4 – Sleep efficiency* 0.1 0.4 0.0 1.1 1.2 1.0
C5 – Sleep disturbances* 0.7 0.6 1.0 1.6 0.6 2.0
C6 – Sleep medication* 0.1 0.5 0.0 0.8 1.3 0.0
C7 – Daytime sleepiness* 0.4 0.6 0.0 1.2 0.9 1.0
Overall score* 3.0 1.5 3.0 9.6 3.1 9.0
The factors that most usually caused sleep difficulties 
among the patients with poor quality sleep were: waking 
up in the middle of the night or too early in the morning 
(34, or 27.9%), getting up in the middle of the night to go 
to the bathroom (29 or 23.8%), and other reasons (28 or 
23.0%). Among patients with good quality of sleep, the 
most common factors causing sleep difficulties were get-
ting up in the middle of the night to go to the bathroom (7 
or 5.7%) and feeling cold (7 or 5.7%). 
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dIScUSSIOn
This study was performed with 122 adults with HIV/
AIDS, of both genders; a similar percentage of men and 
women (55.7% and 44.3%, respectively), with 1.2 men for 
each woman. HIV infection, once considered a predomi-
nantly male disease, no longer presents this difference. 
Over the years, the gender difference has reduced progres-
sively, and the current proportion in Brazil is of 1.5 man for 
each woman(1). The predominant age group was between 
31 and 50 years (70.5% of patients). It is observed that this 
age group continues concentrating the highest number of 
cases in Brazil, although it has been recorded that the pop-
ulation aged 50 years or older has increased(1).
It may be considered that the patients had a low ed-
ucational level, as well as a low reported family income, 
with an expressive percentage of unemployed patients, 
despite their being in a productive age. In association with 
the patients’ low education level, the fact that they live 
in regions that add adverse factors, such as the lack of 
infrastructure, scarce services and restricted public poli-
cies, in addition to people with a low income, increase 
the occurrence of problems, such as alcohol and drug use 
and the prevalence of sexually transmissible diseases(11). 
Some studies show there is a greater incidence of AIDS 
among men and women with a lower educational level, 
with a small variation across the regions of Brazil, and a 
shift, with time, from groups with a higher education level 
to those with a lower education(12). Furthermore, over the 
last few years there has been a process of centralization 
and pauperization of the epidemics(11).
The mean time since diagnosis, nearly ten years, as 
well as the long treatment with antiretroviral drugs (a 
mean 8.1 years) are in agreement with national epidemio-
logic studies, which have shown that the survival rates of 
HIV/AIDS patients has increased, and recently achieved a 
median of nine years. In this sense, the use of antiretrovi-
ral drugs had a decisive participation(13). 
Most patients became infected with HIV through sex. 
This is in line with national data(1,13), which show that sex 
is the main form of HIV transmission. Today, it is observed 
that the high proportion of infected women is due to het-
erosexual relationships, probably their partners, and that 
the prevalence among drug users has fallen(1) because of 
harm reduction programs and the higher mortality among 
drug users. Most patients (62.3%) were in an advanced 
stage of the disease, i.e., stage C. However, 59% of the 
subjects had an undetectable viral load on their medical 
record. No national data were available regarding these 
characteristics.
Most of the present study patients (53.3%) reported 
having good quality sleep. It should be emphasized that 
yet a significant part, 46.7%, experienced poor quality 
sleep. These data partly disagree with other studies on 
the quality of sleep of HIV/AIDS patients, which report al-
tered sleep quality patterns in greater percentages (80% 
to 100%), attributed to the HIV infection, itself, an other 
related factors(7-8,14). 
The mean score on the PSQI-BR was 6.1 (±4.1). Other 
studies with HIV/AIDS patients obtained a mean score of 
6.7(± 3.8)(15), 8.1(± 3.9)(16), 8.5(4.0)(17), 9.4(± 4.4)(14), 10.0(± 
5.0)(18) and 12.3 (± 3.9)(8). It is emphasized that these stud-
ies were performed with smaller samples compared to 
the present study, and that, in some, the majority of par-
ticipants were men(15,17-18) while in others the majority was 
women(8,14,16), and in different proportions than that of the 
present study. Furthermore, the authors investigated fac-
tors associated with the quality of sleep that were not ad-
dressed herein, such as depression, stress, and treatment 
adherence, which could partly explain the differences 
observed. The subjects’ age was the most similar factor 
across the studies, and other aspects regarding the sam-
ple, such as time since diagnosis, treatment time, use of 
antiretroviral drugs, and stage of the disease, in addition 
to not being provided in detail in every study, apparently 
did not help explain these differences. 
The habitual sleep characteristics of patients who re-
ported having good quality sleep were similar to those of 
healthy adults, with a mean duration of eight hours, mean 
latency of 15 minutes and efficiency of 95%(4). It is impor-
tant to highlight that the patients who reported experi-
encing poor quality sleep did not present an expressive 
deterioration of sleep patterns, which had a duration near 
six and a half hours, mean latency of 32 minutes, and ef-
ficiency of 80%. 
Other studies using the PSQI found similar sleep pat-
terns only for the present study subjects with poor quality 
sleep, or further deteriorated: 64%(8) to 75%(17) of patients 
presented a sleep duration of less than seven hours, which 
occurred in 54% of patients with poor quality sleep in the 
present study; latency greater than 30 minutes was re-
ported in 51%(17), 52%(14) and 70%(8), against 68% observed 
in the present study, which was the only compromised 
characteristics compared to the others; in others, 13%(17), 
22%(8) and 33%(14) of patients reported sleeping less than 
five hours every night, e 14%(17), 22%(8) and 26%(14) had a 
sleep efficiency of less than 65%. These characteristics 
were observed, respectively, in 32% and 21% of patients 
with poor quality sleep, and in 10% and 11% of all patients 
in the preset study. Some authors did not report these 
characteristics in their studies(15-16,18).
Only 18.9% of patients reported high daytime sleepi-
ness, or, considering the patients with poor sleep quality 
exclusively, 35%. In other studies, these complaints were 
referred by 25%(17), 42%(14) and 68%(8) of patients. Daytime 
sleepiness, observed more frequently among patients 
with poor quality sleep, may be related to the daily effort 
and fatigue(14). This may be assigned to the fact that these 
patients’ sleep at night is not sufficiently repairing, due to 
the frequent interruptions.
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Indeed, the factors that caused the most nocturnal 
sleep problems, observed among the patients with poor 
quality sleep were: waking up in the middle of the night 
or too early in the morning (60%), needing to get up to go 
to the bathroom (51%) and others (49%), particularly pre-
occupations. Interrupted sleep is common in this popula-
tion, and was observed in 44% of the patients in another 
study(7). Among the patients with good quality sleep, the 
most referred factors were getting up to go to the bath-
room and feeling cold, but in a small proportion, affecting 
11%.
With the purpose to investigate these aspects further, 
the sociodemographic characteristics of the patients were 
analyzed as a function of the quality of sleep. 
An association was found between good quality sleep 
and having a partner. Sleep studies with HIV patients do 
not explore this aspect. However, considering that qual-
ity of sleep is related to quality of life, it is suggested that 
individuals who are well emotionally and psychologically 
have a better quality of sleep. Having a partner, despite 
the stigma and discrimination that still affect HIV/AIDS pa-
tients, could be decisive to improve their quality of life, 
with an indirect positive effect on the quality of sleep(19). 
One unexpected finding should be highlighted: a 
smaller percentage of patients who maintained the risk 
behavior experienced poor quality of sleep compared to 
those who did not maintain the behavior. Literature dos 
not have any information in this respect. A careful specu-
lation may be made, that these patients were probably 
less concerned with their disease, and this could reflect 
on their quality of sleep. The fact that a small percentage 
of patients maintained the risk behavior (15.6%) could 
also cause a bias in the statistical test. 
Another contradictory finding was the greater propor-
tion of patients with poor quality of sleep among those 
who did not take efavirenz compared to those who took 
this retroviral drug. Efavirenz has been pointed out as 
being harmful to the quality of sleep, changing its inter-
nal structure, reducing duration, increasing latency, and 
causing nightmares(20). Other authors have observed slight 
alterations on the sleep architecture, but not on its effi-
ciency, and remembering dreams vividly. Nevertheless, pa-
tients reported being satisfied with their quality of sleep, 
suggesting changes that were more objective than subjec-
tive in nature(21), which helps explain the study findings. 
The largest proportion of patient with good quality of 
sleep was among those with an undetectable viral load. 
This may be directly related to the symptoms that emerge 
as the disease progresses, in addition to the preoccupa-
tions, anxiety and the need to manage symptoms. Other 
authors found an association between quality of sleep 
and HIV-related symptoms, pain, fatigue, depression, anx-
iety, and the number of adults living in the household, but 
not related to the viral load(8). However, two other studies 
found an association between poor adherence to antiret-
roviral treatment and poor quality of sleep(16,22). In one of 
those studies(22), 75% of the subjects with poor adherence 
reported experiencing sleep disturbances, compared to 
45% of those with good adherence . The authors found 
that among the subjects with good adherence a high 
percentage of individuals had an undetectable viral load. 
These findings agree with the association between an un-
detectable viral load and good quality sleep, found in the 
present study.
It has been observed there is a relation between the 
progression of the disease and poor quality of sleep, and 
individuals with HIV/AIDS in an advanced stage of the 
disease can experience cerebral symptoms that increase 
sleep disturbances, such as insomnia(8,20). This association 
was not observed in the present study, in which 51.3% of 
patients in stage C of the disease experienced good qual-
ity sleep. In this sense, the viral load obtained through 
laboratory exams should also be considered, as previously 
referred. It should also be noted that patients with poor 
quality of sleep in this stage of the disease accounted for 
an expressive proportion (48.7%), and their sleep qual-
ity should be habitually assessed. As the infection pro-
gresses, the immunological condition of HIV/AIDS patients 
worsens, and, thus, they may present physical symptoms 
such as pain, fever, coughing, dyspnea, nocturnal sweat-
ing, and diarrhea, which cause sleep disturbances and 
habit changes(8). 
Further studies should aim at clarifying the differences 
between people with HIV/AIDS who experience good and 
bad quality of sleep, performing a deeper investigation on 
the factors that have appeared as most relevant in other 
studies: anxiety, depression, fatigue, HIV-related symp-
toms, stress, and adherence to the antiretroviral treat-
ment(8,14, 22). 
Special emphasis should be given to the significant as-
sociation between good quality sleep and the undetect-
able viral load, which rises questions, with the due cau-
tion, about the relationships between the adherence to 
treatment and the quality of sleep, already referred in 
literature. Theses relationships should be investigated, 
considering that seeking good adherence to treatment is 
a challenge and a priority for nurses who treat individuals 
with HIV/AIDS. 
cOncLUSIOn
In the present study, performed with 122 adults with 
HIV/AIDS, of both genders, it was observed a high preva-
lence (46.7%) of people with poor quality of sleep ac-
cording to the Pittsburgh Sleep Quality Index (PSQI-BR). 
Although the sleep patterns did not appear to be expres-
sively deteriorated in subjects with poor quality of sleep 
(a mean 6.4 hours of sleep, mean latency of 32 minutes 
and efficiency of 80%), these rates deserve the attention 
of healthcare professionals. Subjects with good quality 
sleep presented similar sleep patterns to those of healthy 
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adults (mean duration of eight hours, latency of less than 
fifteen minutes and efficiency of 95%). It was found that 
good quality of sleep was associated with having a partner 
and an undetectable viral load. Waking up in the middle 
of the night or too early in the morning, having to use 
the bathroom at night, having preoccupations and feeling 
cold were the main factors that disturbed nocturnal sleep.
Sleep complaints are prevalent among people with 
HIV/AIDS, but they apparently remain undervalued by 
healthcare professionals. It is recommended that these 
professionals make a systematic inclusion of questions re-
garding sleep when assessing patients with HIV/AIDS. This 
way, it will be possible to make an early identification of 
the sleep-related complaints and plan interventions that 
avoid or minimize the worsening of the complaints and 
subsequent deterioration of the quality of sleep, which ef-
fects will eventually affect the patients’ overall health and 
quality of life. 
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